Noninvasive measurement of oxygenation using quantitative susceptibility mapping

使用定量磁化率图无创测量氧合

• 批准号: 10322146
• 负责人: Pascal Spincemaille
• 金额: $ 83.07万
• 依托单位: WEILL MEDICAL COLL OF CORNELL UNIV
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-01-01 至 2025-12-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10322146
• 关键词: 3-Dimensional; Activities of Daily Living; Address; Adult; Affect; Agreement; Ally; Anatomy; Blood; Breathing; Calibration; Cardiac; Cardiac Catheterization Procedures; Cardiac Output; Catheterization; Cellular Morphology; Cessation of life; Clinical; Clinical Research; Complex; Data; Decision Making; Disease; Disease Progression; Dose; Dyspnea; Early Diagnosis; Erythrocytes; Evaluation; Exercise Test; Financial compensation; Genes; Goals; Heart; Hospitalization; Imaging Techniques; Impairment; Ionizing radiation; Knowledge; Left; Life; Liver diseases; Lung; Magnetic Resonance Imaging; Magnetism; Measurement; Measures; Methods; Modeling; Monitor; Motion; Organ; Outcome; Outcomes Research; Oxygen; Patient-Focused Outcomes; Patients; Perfusion; Phase; Physics; Physiologic Monitoring; Physiologic pulse; Predisposition; Prevalence; Property; Protons; Pulmonary Hypertension; Radiation exposure; Reference Standards; Relaxation; Reproducibility; Research; Risk; Scanning; Severities; Signal Transduction; Symptoms; Techniques; Technology; Testing; Therapeutic; Time; Tissues; Transplantation; Treatment outcome; United States; Validation; Vascular Diseases; Walking; base; cell water; clinical practice; clinical prognosis; cohort; computerized data processing; data acquisition; end stage disease; follow-up; heart function; hemodynamics; human old age (65+); hypertension treatment; improved; improved outcome; indexing; insight; mortality; nervous system disorder; novel; predict clinical outcome; pressure; prospective; pulmonary arterial pressure; reconstruction; respiratory; stem; treatment optimization

PROJECT SUMMARY/ABSTRACT The goal of this research is to develop cardiac quantitative susceptibility mapping (QSM) for non-invasive meas- urement of blood oxygen saturation, towards the long-term objective of improving early diagnosis, therapeutic decision-making, and clinical outcomes for patients with pulmonary hypertension (PH). PH is a progressive and life shortening disorder affecting ~10% of adults over age 65. Given that PH can be irreversible in its later stages, early diagnosis and physiologic monitoring are critically important. Impaired oxygenation of the lungs and heart chambers (cardiac oxygenation) is a key manifestation of PH that impacts symptoms and clinical outcomes. Increased pulmonary arterial pressure in PH impairs pulmonary oxygen exchange, decreasing delivery of oxy- genated blood to the left heart. Systemic cardiac output is often compromised in PH, resulting a larger differential blood oxygen saturation between the left and right heart. Invasive catheterization (cath) is currently used to measure cardiac oxygenation but entails procedural risks, ionizing radiation exposure, and is impractical for early diagnosis and serial monitoring - a non-invasive method to accurately measure blood oxygenation would be of substantial utility. MRI is well suited for PH assessment as it enables integrated evaluation of pulmonary anat- omy, pressure, as well as cardiac function and remodeling - blood oxygenation is a key gap in MRI evaluation of PH. This gap stems from limitations in current pulse sequence technology rather than fundamental MRI physics. It is well known that deoxygenation changes the magnetic susceptibility of blood. These changes have tradition- ally been probed using a magnitude property of the MR signal: the transverse relaxation time (T2). However, this requires patient-specific calibration that is difficult in clinical practice. In contrast, QSM relies on the phase of the MR signal to directly measure susceptibility and thus cardiac oxygenation. We have obtained highly encouraging preliminary data for QSM measurement of cardiac blood oxygenation, with close agreement between QSM and oxygenation measured invasively. We have identified key challenges for developing cardiac QSM, including motion suppression and prolonged scan times. The current research proposes to develop an accelerated cardiac QSM method, and to test QSM in relation to oxygenation on invasive cath, as well as effort tolerance and clinical prognosis. Study Aims are as follows: (1) Develop accelerated cardiac QSM using free-breathing acquisition and optimized reconstruction. (2) Test accelerated and current cardiac QSM among PH patients in comparison to T2-based cardiac oxygenation and the reference standard of invasive cardiac catheterization. (3) Determine whether cardiac QSM stratifies clinical severity and predicts PH disease progression. The expected outcome of this research is a non-invasive method for measuring cardiac oxygenation – a critically important marker in PH that currently relies on invasive testing. Given the increasing prevalence and therapeutic options for this serious condition, non-invasive oxygenation assessment by cardiac QSM holds broad significance towards the goal of early diagnosis, therapy optimization, and improved clinical outcomes for millions of patients with PH.

项目总结/文摘